Dr. Vitaly Terushkin is a fellowship-trained Mohs surgeon and triple board-certified in Dermatology, Dermatopathology, and Micrographic Dermatologic Surgery. He is one of a few Mohs surgeons in the United States to have also completed a fellowship in dermatopathology. Dr. Terushkin is the first Mohs surgeon in New York City to have treated melanoma with Mohs surgery and the MART-1 immunostain. His practice is limited to Mohs and reconstructive surgery for melanoma and non-melanoma skin cancer. He also teaches dermatology residents at Weill Cornell Medical College.
Since entering practice, Dr. Terushkin has performed over 13,000 Mohs surgeries. This includes over 1000 melanomas treated with Mohs surgery and the MART-1 immunostain.
Dr. Terushkin graduated summa cum laude from Brandeis University with a degree in Neuroscience and then attended NYU School of Medicine. While in medical school, he spent an extra year conducting research in cutaneous oncology at the Memorial Sloan-Kettering Cancer Center. He completed his internship in internal medicine at the Mount Sinai Medical Center and his dermatology residency at NYU, where he also served as chief resident. Dr. Terushkin then completed a fellowship in Micrographic surgery and dermatologic oncology under the guidance of Drs. Zitelli and Brodland, recognized leaders in the field. He subsequently returned to NYU to complete a fellowship in dermatopathology.
In 2021 and 2022, Dr. Terushkin was selected as a Castle Connolly Top Doctor. He has published over 30 peer-reviewed articles and book chapters. He is a member of the American College of Mohs Surgery, American Academy of Dermatology, and Dermatologic Society of Greater New York. He is a peer reviewer for several professional medical journals. He is fluent in Russian and conversational in Spanish.